Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

An Evidence Based Perspective on mRNA-SARS-CoV-2 Vaccine Development
Fuzhou Wang, Richard M. Kream, George B. Stefano
Medical Science Monitor (2020) Vol. 26
Open Access | Times Cited: 232

Showing 1-25 of 232 citing articles:

A systematic review of SARS-CoV-2 vaccine candidates
Yetian Dong, Tong Dai, Yujun Wei, et al.
Signal Transduction and Targeted Therapy (2020) Vol. 5, Iss. 1
Open Access | Times Cited: 541
COVID-19 (Novel Coronavirus 2019) - recent trends.
Kannan Subbaram, P. Shaik Syed Ali, A. Sheeza, et al.
DOAJ (DOAJ: Directory of Open Access Journals) (2020) Vol. 24, Iss. 4, pp. 2006-2011
Closed Access | Times Cited: 511
Solid Lipid Nanoparticles for Drug Delivery: Pharmacological and Biopharmaceutical Aspects
Sebastián Scioli Montoto, Giuliana Muraca, María Esperanza Ruiz
Frontiers in Molecular Biosciences (2020) Vol. 7
Open Access | Times Cited: 490
Long-Term Respiratory and Neurological Sequelae of COVID-19
Fuzhou Wang, Richard M. Kream, George B. Stefano
Medical Science Monitor (2020) Vol. 26
Open Access | Times Cited: 418
COVID-19: Characteristics and Therapeutics
Rameswari Chilamakuri, Saurabh Agarwal
Cells (2021) Vol. 10, Iss. 2, pp. 206-206
Open Access | Times Cited: 266
Structural features of coronavirus SARS-CoV-2 spike protein: Targets for vaccination
Ariane Sternberg, Cord Naujokat
Life Sciences (2020) Vol. 257, pp. 118056-118056
Open Access | Times Cited: 222
A Snapshot of the Global Race for Vaccines Targeting SARS-CoV-2 and the COVID-19 Pandemic
Colin Funk, Craig A. Laferrière, Ali Ardakani
Frontiers in Pharmacology (2020) Vol. 11
Open Access | Times Cited: 206
Nanoparticle-Based Strategies to Combat COVID-19
Riddhiman Medhi, Pannaree Srinoi, Nhat M. Ngo, et al.
ACS Applied Nano Materials (2020) Vol. 3, Iss. 9, pp. 8557-8580
Open Access | Times Cited: 194
Genetics and genomics of SARS-CoV-2: A review of the literature with the special focus on genetic diversity and SARS-CoV-2 genome detection
Azadeh Rahimi, Azin Mirzazadeh, Soheil Tavakolpour
Genomics (2020) Vol. 113, Iss. 1, pp. 1221-1232
Open Access | Times Cited: 168
Proof-of-concept of a low-dose unmodified mRNA-based rabies vaccine formulated with lipid nanoparticles in human volunteers: A phase 1 trial
Cassandra Aldrich, Isabel Leroux‐Roels, Katell Bidet Huang, et al.
Vaccine (2021) Vol. 39, Iss. 8, pp. 1310-1318
Open Access | Times Cited: 161
Drugs targeting various stages of the SARS-CoV-2 life cycle: Exploring promising drugs for the treatment of Covid-19
Poduri Ramarao, Gaurav Joshi, Gowraganahalli Jagadeesh
Cellular Signalling (2020) Vol. 74, pp. 109721-109721
Open Access | Times Cited: 146
Autoimmune post-COVID vaccine syndromes: does the spectrum of autoimmune/inflammatory syndrome expand?
Luis J. Jara, Olga Vera‐Lastra, Naim Mahroum, et al.
Clinical Rheumatology (2022) Vol. 41, Iss. 5, pp. 1603-1609
Open Access | Times Cited: 113
Genetics and sports performance: the present and future in the identification of talent for sports based on DNA testing
David Varillas‐Delgado, Juan Del Coso, Jorge Gutiérrez‐Hellín, et al.
European Journal of Applied Physiology (2022) Vol. 122, Iss. 8, pp. 1811-1830
Open Access | Times Cited: 77
The effects of PEGylation on LNP based mRNA delivery to the eye
Renee C. Ryals, Siddharth Patel, Chris Acosta, et al.
PLoS ONE (2020) Vol. 15, Iss. 10, pp. e0241006-e0241006
Open Access | Times Cited: 138
Viral Pandemics of the Last Four Decades: Pathophysiology, Health Impacts and Perspectives
Shubhadeep Roychoudhury, Anandan Das, Pallav Sengupta, et al.
International Journal of Environmental Research and Public Health (2020) Vol. 17, Iss. 24, pp. 9411-9411
Open Access | Times Cited: 125
Substance Use Disorder in the COVID-19 Pandemic: A Systematic Review of Vulnerabilities and Complications
Yufeng Wei, Rameen Shah
Pharmaceuticals (2020) Vol. 13, Iss. 7, pp. 155-155
Open Access | Times Cited: 113
Engineering of the current nucleoside-modified mRNA-LNP vaccines against SARS-CoV-2
Javier T. Granados‐Riveron, Guillermo Aquino‐Jarquín
Biomedicine & Pharmacotherapy (2021) Vol. 142, pp. 111953-111953
Open Access | Times Cited: 98
Advances in gene-based vaccine platforms to address the COVID-19 pandemic
Deborah Pushparajah, Salma Jimenez, Shirley Wong, et al.
Advanced Drug Delivery Reviews (2021) Vol. 170, pp. 113-141
Open Access | Times Cited: 95
Progress and Pitfalls in the Quest for Effective SARS-CoV-2 (COVID-19) Vaccines
Katie L. Flanagan, Emma Best, Nigel W. Crawford, et al.
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 94
COVID-19 Vaccines: “Warp Speed” Needs Mind Melds, Not Warped Minds
John P. Moore, Per Johan Klasse
Journal of Virology (2020) Vol. 94, Iss. 17
Open Access | Times Cited: 92
The 2020 race towards SARS-CoV-2 specific vaccines
Tomasz M. Karpiński, Marcin Ożarowski, Agnieszka Seremak‐Mrozikiewicz, et al.
Theranostics (2020) Vol. 11, Iss. 4, pp. 1690-1702
Open Access | Times Cited: 91
Nanoparticle-Mediated Cytoplasmic Delivery of Messenger RNA Vaccines: Challenges and Future Perspectives
Zimei Wu, Tonglei Li
Pharmaceutical Research (2021) Vol. 38, Iss. 3, pp. 473-478
Open Access | Times Cited: 87
Comparative review of respiratory diseases caused by coronaviruses and influenza A viruses during epidemic season
Chao Jiang, Xingang Yao, Yulin Zhao, et al.
Microbes and Infection (2020) Vol. 22, Iss. 6-7, pp. 236-244
Open Access | Times Cited: 85
Efficacy and Safety of COVID-19 Vaccines in Phase III Trials: A Meta-Analysis
Haoyue Cheng, Zhicheng Peng, Wenliang Luo, et al.
Vaccines (2021) Vol. 9, Iss. 6, pp. 582-582
Open Access | Times Cited: 85
An Overview of Vaccine Development for COVID-19
Seyed Hossein Shahcheraghi, Jamshid Ayatollahi, Alaa A. A. Aljabali, et al.
Therapeutic Delivery (2021) Vol. 12, Iss. 3, pp. 235-244
Open Access | Times Cited: 75
Page 1 - Next Page

Scroll to top